SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001824293-24-000060
Filing Date
2024-06-14
Accepted
2024-06-14 08:08:20
Documents
19
Period of Report
2024-06-13
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K val-20240613.htm   iXBRL 8-K 28194
2 EX-3.1 ex31_certificateofamendm.htm EX-3.1 657
3 EX-99.1 ex991_pressreleasejunereve.htm EX-99.1 13725
7 GRAPHIC ex31_certificateofamendm001.jpg GRAPHIC 270408
8 GRAPHIC image_0.jpg GRAPHIC 38371
9 GRAPHIC val-20240613_g1.jpg GRAPHIC 16879
10 GRAPHIC val-20240613_g2.jpg GRAPHIC 1656
  Complete submission text file 0001824293-24-000060.txt   635730

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT val-20240613.xsd EX-101.SCH 1913
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT val-20240613_lab.xml EX-101.LAB 24352
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT val-20240613_pre.xml EX-101.PRE 14125
22 EXTRACTED XBRL INSTANCE DOCUMENT val-20240613_htm.xml XML 2915
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037 (619) 400-1171
GRI BIO, Inc. (Filer) CIK: 0001824293 (see all company filings)

IRS No.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40034 | Film No.: 241043193
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)